Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 437

1.

Estrogen receptor genotypes and haplotypes associated with breast cancer risk.

Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K.

Cancer Res. 2004 Dec 15;64(24):8891-900.

2.

Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.

Rivadeneira F, van Meurs JB, Kant J, Zillikens MC, Stolk L, Beck TJ, Arp P, Schuit SC, Hofman A, Houwing-Duistermaat JJ, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2006 Sep;21(9):1443-56.

3.

Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.

Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC.

J Natl Cancer Inst. 2005 Jan 5;97(1):51-9.

PMID:
15632380
4.

Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy.

Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B.

PLoS One. 2012;7(7):e40162. doi: 10.1371/journal.pone.0040162. Epub 2012 Jul 10.

5.

Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.

Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT.

Cancer Res. 2003 Nov 15;63(22):7624-9.

6.

Estrogen receptor polymorphisms and the risk of endometrial cancer.

Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ.

BJOG. 2009 Jul;116(8):1053-61. doi: 10.1111/j.1471-0528.2009.02185.x. Epub 2009 May 11.

7.

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women.

Wang J, Higuchi R, Modugno F, Li J, Umblas N, Lee J, Lui LY, Ziv E, Tice JA, Cummings SR, Rhees B.

Breast Cancer Res Treat. 2007 Dec;106(2):273-80. Epub 2007 Feb 1.

PMID:
17268813
8.

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE.

Hum Mol Genet. 2003 Oct 15;12(20):2679-92. Epub 2003 Aug 27.

PMID:
12944421
9.

Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer.

Maguire P, Margolin S, Skoglund J, Sun XF, Gustafsson JA, Børresen-Dale AL, Lindblom A.

Breast Cancer Res Treat. 2005 Nov;94(2):145-52.

PMID:
16261413
10.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

11.

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S.

Cancer Detect Prev. 2009;32(5-6):386-94.

PMID:
19588543
12.

Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.

Tsezou A, Tzetis M, Gennatas C, Giannatou E, Pampanos A, Malamis G, Kanavakis E, Kitsiou S.

Breast. 2008 Apr;17(2):159-66. Epub 2007 Sep 29.

PMID:
17904846
13.

Microsatellite profile in hormonal receptor genes associated with breast cancer.

Iobagiu C, Lambert C, Normand M, Genin C.

Breast Cancer Res Treat. 2006 Jan;95(2):153-9. Epub 2005 Nov 30.

PMID:
16317584
14.

A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.

Yu KD, Rao NY, Chen AX, Fan L, Yang C, Shao ZM.

Breast Cancer Res Treat. 2011 Feb;126(1):37-45. doi: 10.1007/s10549-010-0891-2.

PMID:
20390341
15.

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.

Clin Cancer Res. 2005 Jul 1;11(13):4775-8.

16.

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.

Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G; Kathleen Cuningham Consortium for Research in Familial Breast Cancer.

Breast Cancer Res Treat. 2008 May;109(1):91-9. Epub 2007 Jun 26.

PMID:
17592773
17.

HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.

Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):213-9.

18.

The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes.

Sonestedt E, Ivarsson MI, Harlid S, Ericson U, Gullberg B, Carlson J, Olsson H, Adlercreutz H, Wirfält E.

J Nutr. 2009 May;139(5):993-1001. doi: 10.3945/jn.108.101691. Epub 2009 Mar 25.

19.

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.

Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.

J Natl Cancer Inst. 2005 Apr 6;97(7):525-32.

PMID:
15812078
20.

Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population.

Joshi G, Pradhan S, Mittal B.

Cephalalgia. 2010 Mar;30(3):311-20. doi: 10.1111/j.1468-2982.2009.01967.x. Epub 2010 Feb 11.

PMID:
19673915

Supplemental Content

Support Center